SCHEMBL9943959

SCHEMBL9943959

CC(=O)OC[C@@H]1CC(O)O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ NLRP3 Q96P20 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CA12 O43570 5/20 0.35
▸ CA1 P00915 5/20 0.35
▸ CA2 P00918 5/20 0.35
▸ CA9 Q16790 5/20 0.35
▸ CYP2D6 P10635 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ TSHR P16473 3/20 0.33
▸ NR3C1 P04150 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ DRD4 P21917 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ CYP3A4 P08684 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9943957 1.00 PDK1 (0.41) PDK1ALDH1A1NLRP3HSD17B10LMNA
SCHEMBL9943958 1.00 PDK1 (0.41) PDK1ALDH1A1NLRP3HSD17B10LMNA
SCHEMBL1263449 0.93 PDK1 (0.37) PDK1ALDH1A1NLRP3HSD17B10LMNA
SCHEMBL20146253 0.93 PDK1 (0.37) PDK1ALDH1A1NLRP3HSD17B10LMNA
SCHEMBL21662371 0.93 PDK1 (0.37) PDK1ALDH1A1NLRP3HSD17B10LMNA
SCHEMBL20776490 0.84 PDK1 (0.39) PDK1ALDH1A1NLRP3HSD17B10LMNA
SCHEMBL19047773 0.80 PDK1 (0.36) PDK1ALDH1A1NLRP3HSD17B10LMNA
SCHEMBL13621081 0.80 PDK1 (0.36) PDK1ALDH1A1NLRP3HSD17B10LMNA
SCHEMBL16126990 0.80 PDK1 (0.36) PDK1ALDH1A1NLRP3HSD17B10LMNA
SCHEMBL17226048 0.79 PDK1 (0.38) PDK1ALDH1A1NLRP3HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655650-B1 ENZYMATIC SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT AND INTERMEDIATES THEREOF LEK PHARMACEUTICALS (SI) 2017-12-20 — — EP disclosed
US-20130337485-A1 ENZYMATIC SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT AND INTERMEDIATES THEREOF LEK PHARMACEUTICALS D.D (SI) 2013-12-19 — — US disclosed
EP-2655650-A2 ENZYMATIC SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT AND INTERMEDIATES THEREOF LEK Pharmaceuticals d.d. (SI) 2013-10-30 — — EP disclosed
WO-2012095244-A2 ENZYMATIC SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT AND INTERMEDIATES THEREOF LEK PHARMACEUTICALS D.D. (SI) 2012-07-19 — — WO disclosed
EP-2465936-A1 Enzymatic synthesis of statins and intermediates thereof LEK Pharmaceuticals d.d. (SI) 2012-06-20 — — EP disclosed
Send feedback